[1]
Ha, T.A., Nguyen, T.N., Nguyen, T.A., Huynh, T.-T.T., Nguyen, A.-D.H. and Quang, M.T. 2026. CRISPR/Cas9 Editing of the β-Globin Locus in Sickle Cell Disease and β-Thalassemia: Mechanistic Rationale, Clinical Evidence, and Future Directions. Trends in Sciences. 23, 7 (Mar. 2026), 12982. DOI:https://doi.org/10.48048/tis.2026.12982.